Skip to main content

ORIGINAL RESEARCH article

Front. Cardiovasc. Med., 13 January 2022
Sec. Cardiovascular Biologics and Regenerative Medicine
Volume 8 - 2021 | https://doi.org/10.3389/fcvm.2021.798091

RETRACTED: STK35 Gene Therapy Attenuates Endothelial Dysfunction and Improves Cardiac Function in Diabetes

Darukeshwara Joladarashi1,2 Yanan Zhu1 Matthew Willman1 Kevin Nash1 Maria Cimini2 Rajarajan Amirthalingam Thandavarayan3 Keith A. Youker3 Xuehong Song1 Di Ren4 Ji Li4 Raj Kishore2 Prasanna Krishnamurthy5* Lianchun Wang1*
  • 1Department of Molecular Pharmacology & Physiology, Morsani College of Medicine, Bryd Alzheimer's Research Institute, University of South Florida, Tampa, FL, United States
  • 2Center for Translational Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States
  • 3Houston Methodist DeBakey Heart & Vascular Center, Houston, TX, United States
  • 4Department of Surgery, Morsani College of Medicine, University of South Florida, Tampa, FL, United States
  • 5Department of Biomedical Engineering, The University of Alabama at Birmingham, Birmingham, AL, United States

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Joladarashi D, Zhu Y, Willman M, Nash K, Cimini M, Thandavarayan RA, Youker KA, Song X, Ren D, Li J, Kishore R, Krishnamurthy P and Wang L (2022) STK35 Gene Therapy Attenuates Endothelial Dysfunction and Improves Cardiac Function in Diabetes. Front. Cardiovasc. Med. 8:798091. doi: 10.3389/fcvm.2021.798091

Received: 19 October 2021; Accepted: 22 December 2021;
Published: 13 January 2022; Retracted: 09 May 2023.

Edited by:

Nicolle Kraenkel, Charité University Medicine Berlin, Germany

Reviewed by:

Zhao Wang, City of Hope National Medical Center, United States
Amaresh Ranjan, Midwestern University, United States
Download